At Norstella, everything begins and ends with the patient.
Our mission is simple: to help our clients bring life-saving therapies to market quicker—and help patients in need.
We make this possible by helping our clients navigate the complexities at every step of the drug development lifecycle — from pipeline to patient. As one of the world’s largest pharma intelligence solution providers, Norstella unites market‑leading companies with a shared purpose: Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group. Together, we deliver the connected insights biopharma teams rely on to make confident decisions.
Our integrated expertise empowers clients to:
- Assess market needs and competitive dynamics
- Prioritize the right drugs in their portfolios
- Connect patients to clinical trials
- Reduce cost, mitigate risk, and ensure compliance
- Design winning launch strategies with broad patient access
By bringing these capabilities under one roof, we offer an unmatched breadth of real‑world data, market-access intelligence, clinical and commercial insights, and expert advisory support. Our solutions are powered by advanced technologies — including machine learning, predictive analytics, and modern data platforms — enabling faster, smarter decision‑making across the product lifecycle. At Norstella, we don’t just provide information.
We deliver actionable answers — helping the world’s leading pharma, biotech, and life sciences organizations overcome critical challenges in drug development, evidence generation, market access, and patient access.
Together, we’re connecting the dots from pipeline to patient — and shaping a future where life‑saving therapies reach the people who need them most.